Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
758.500.09%
QQQ
708.970.04%
BTC/USD
77232.261.3405%
DIA
521.070.06%
GLD
395.770.15%
TLT
80.690.11%

Indaptus Therapeutics Inc (INDP) Stock Price, Quote, News & History

INDPNASDAQ
Trade with Public
Trade with Public
$2.56
0.4823.08%
At close: Sep 10, 5:00 PM EST
$2.57
0.010.39%
After Hours: 4:23 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Indaptus Therapeutics (INDP) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$2.00
Close
$2.56
Volume / Avg.
3.14M / 702.21K
Day Range
$1.97 - $2.63
52 Wk Range
0.92 - 8.57
Market Cap
$342.43M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
77
Short Interest
0.09%
Days to Cover
1

Recent Indaptus Therapeutics Inc News

Ouster, Datavault AI, Paranovus Entertainment Technology And Other Big Stocks Moving Higher On Monday

U.S. stocks higher with Nasdaq up 2%. Ouster shares rise 15.8%, PAVS gains 92.1%. Other big gains include BTQ, HQ, DGXX, AXTI, DVLT, MVST, IDR, INDP, WDC, GPGI, XE, QBTS.
Avi Kapoor

Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-market trading: BVC, TLK, INDP, APPN, WIX, KB, SSSS, IPSC, AMPL, ICCM, SBSW, ROMA.
Avi Kapoor

Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in pre-market trading. The company recently announced a 1-for-20 reverse stock split.The shares of Marvell Technology Inc (NASDAQ: MRVL) surged in pre-market trading after securing a spot in the S&P 500 index, while Real Messenger Corp (NASDAQ: RMSG) experienced a significant decline. Other gainers in pre-market trading include Dreamland Ltd (NASDAQ: TDIC), Gamehaus Holdings Inc (NASDAQ: GMHS), Nurix Therapeutics Inc (NASDAQ: NRIX), SmartKem Inc (NASDAQ: SMTK), Mountain Lake Acquisition Corp (NASDAQ: MLAC), Battalion Oil Corp (NASDAQ: BATL), Qtrex Quantum Ltd (NASDAQ: QTEX), Bone Biologics Corp (NASDAQ: BBLG), and Cullinan Therapeutics Inc (NASDAQ: CGEM).
Avi Kapoor

Why Solidion Technology Shares Are Rallying Over 50%; Here Are 20 Stocks Moving Premarket

Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing their extreme-climate battery technology.
Avi Kapoor

Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-14.70M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
20.09M
Free Cash Flow (TTM)
-14.70M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
1.40M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$268.66M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
24.14
Earnings Yield % (TTM)
-172.82%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.09

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$7.55M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.00
Close
$2.56
Volume / Avg.
3.14M / 702.21K
Day Range
$1.97 - $2.63
52 Wk Range
0.92 - 8.57
Market Cap
$342.43M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
77
Short Interest
0.09%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Indaptus Therapeutics (INDP) stock?

A

You can purchase shares of Indaptus Therapeutics (NASDAQ:INDP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Indaptus Therapeutics (INDP) competitors?

Q

What is the forecast, or price target, for Indaptus Therapeutics (INDP) stock?

A

Indaptus Therapeutics has a consensus price target of $238.00.

Q

What is the current price for Indaptus Therapeutics (INDP)?

A

The stock price for Indaptus Therapeutics (NASDAQ: INDP) is $2.57 last updated September 10, 2026 at 4:23 PM EDT.

Q

Does Indaptus Therapeutics (INDP) pay a dividend?

A

There are no upcoming dividends for Indaptus Therapeutics.

Q

When is Indaptus Therapeutics (NASDAQ:INDP) reporting earnings?

A

Indaptus Therapeutics does not have any upcoming earnings scheduled.

Q

Is Indaptus Therapeutics (INDP) going to split?

A

There is no upcoming split for Indaptus Therapeutics.

Q

What sector and industry does Indaptus Therapeutics (INDP) operate in?

A

Indaptus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved